News | October 19, 2025
Gujarat Themis Biosyn doubles fermentation production capacity at Vapi
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons
Company will invest approximately ¥16 billion to increase production capacity by approximately 70% to ensure a stable supply
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Subscribe To Our Newsletter & Stay Updated
